4.3 Article

Exonuclease 1 (EXO1) gene variation and melanoma risk

Journal

DNA REPAIR
Volume 11, Issue 3, Pages 304-309

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.dnarep.2011.12.005

Keywords

Melanoma; GWAS; DNA repair; SNP

Funding

  1. NIH [CA122838, CA87969, CA055075]

Ask authors/readers for more resources

Objective: DNA repair pathway genes play an important role in maintaining genomic integrity and protecting against cancer development. This study aimed to identify novel SNPs in the DNA repair-related genes associated with melanoma risk from a genome-wide association study (GWAS). Methods: A total of 8422 SNPs from the 165 DNA repair-related genes were extracted from a GWAS of melanoma risk, including 494 cases and 5628 controls from the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS). We further replicated the top SNPs in a GWAS of melanoma risk from the MD Anderson Cancer Center (1804 cases and 1026 controls). Results: A total of 3 SNPs with P value < 0.001 were selected for in silico replication. One SNP was replicated: rs3902093 [A] in EXO1 promoter region ( P discovery = 6.6 x 10(-4), P-replication = 0.039, P-joint = 2.5 x 10(-4); ORjoint = 0.80, 95% CI: 0.71, 0.90). This SNP was associated with the expression of the EXO1; carriers of the A allele showed lower expression (P=0.002). Conclusion: Our study found that a promoter region SNP in the editing and processing nucleases gene EXO1 was associated with decreased expression of EXO1 and decreased melanoma risk. Further studies are warranted to validate this association and to investigate the potential mechanisms. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available